Brave Warrior Advisors Q1 2026 13F Holdings and Activity Report

I. Institutional Overview

Glenn Greenberg, the seasoned helmsman of Brave Warrior Advisors, has long been regarded as a quintessential practitioner of high-conviction value investing. As we dissect the institutional holdings for the first quarter of 2026, specifically the snapshot ending March 31, 2026, we observe a portfolio that remains a testament to the "Brave Warrior" ethos: a concentrated, unapologetic approach to capital allocation that prioritizes deep fundamental understanding over broad market diversification. With a reported total portfolio market value of approximately $4.04 billion, the institution manages a relatively lean roster of 36 holdings. This structural choice immediately signals an investment style that is far removed from the "closet indexing" prevalent among many large-scale asset managers. Instead, it reflects a "focus investing" philosophy where the manager is willing to place significant bets on a handful of businesses that meet rigorous criteria for competitive advantage, management quality, and valuation.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

II. Sector Allocation Analysis

The most striking feature of the sector allocation is the overwhelming concentration in the top three sectors: Financials, Healthcare, and Consumer Discretionary. Together, these three sectors account for approximately 66.26% of the total portfolio. This level of focus indicates a "highly focused" investment strategy. When an institution allocates over a third of its capital to Financials, it is making a profound statement on the interest rate environment and the health of the credit markets. In the context of 2026, this suggests a belief that the financial sector—particularly niche credit and insurance—is well-positioned to capture spreads in a "higher-for-longer" or "stabilizing" rate environment. It is not a bet on traditional "too big to fail" banks, as evidenced by the exit from U.S. Bancorp, but rather a bet on specialized financial engines like OneMain Holdings and SLM Corporation.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

III. Top 10 Holdings Deep Dive

TD SYNNEX remains the largest position in the portfolio, representing 12.75% of the total assets. This is a classic "conviction holding" for Glenn Greenberg. Despite a slight reduction of 3.46% in the number of shares held this quarter, the portfolio weight actually increased from 11.13% to 12.75%. This divergence indicates that the stock price of TD SYNNEX outperformed the rest of the portfolio significantly during the quarter, leading to an "organic" increase in its weight despite the minor profit-taking. TD SYNNEX operates in the critical but low-margin world of IT distribution. It is the backbone of the technology supply chain, helping manufacturers like Dell, HP, and Cisco reach a vast network of resellers. The investment logic here is rooted in the "indispensable intermediary" theme. As businesses in 2026 continue to upgrade their infrastructure for AI and hybrid cloud environments, TD SYNNEX acts as the primary conduit for this hardware and software. The institution’s willingness to let this position grow to nearly 13% of the portfolio suggests they view the company’s valuation as still attractive relative to its dominant market position and cash-flow generation capabilities.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

IV. Major Buys/Additions

The $331.63 million investment in ICON is the defining move of the quarter. As a "New" position that immediately vaulted to the number three spot, it represents a "growth acceleration bet." The motivation behind this addition is likely twofold. First, the valuation of CROs (Clinical Research Organizations) may have reached a "trough" in late 2025 due to a temporary slowdown in biotech funding, providing a "valuation trough mining" opportunity for a value investor like Greenberg. Second, the long-term fundamentals of ICON are incredibly robust. As the pharmaceutical industry moves toward more complex therapies (such as gene editing and personalized medicine), the expertise required to navigate global regulatory hurdles and manage multi-country clinical trials becomes more valuable. ICON’s scale allows it to partner with the world’s largest pharma companies on a "strategic provider" basis, creating a sticky, high-margin revenue stream. This move significantly increases the "offensiveness" of the portfolio by adding a high-growth healthcare engine to the existing value-heavy mix.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

V. Major Sells and Exits

The reduction of $69.66 million in MPLX (a 27.28% cut in shares) is the most significant "cash flow retrieval" operation of the quarter. MPLX, a master limited partnership focused on midstream energy infrastructure, has been a stellar performer for the portfolio, providing high yields and steady capital appreciation. However, a reduction of nearly 30% suggests a "Major Strategic Contraction." The institution likely views the energy infrastructure cycle as reaching a temporary peak or believes that the total return potential from current levels is lower than the newly identified opportunity in ICON. This is a classic "Sell A to Buy B" scenario. By trimming a high-yield energy play, the institution is freeing up capital for a higher-growth healthcare play, effectively shifting the portfolio's "beta" toward growth.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

VI. Investment Insights and Risk Warnings

The overarching theme of Brave Warrior Advisors’ adjustments in the first quarter of 2026 can be summarized as: "From Infrastructure to Intelligence: Pivoting Toward High-Moat Service Platforms." The institution is moving away from the "physical" infrastructure of the economy—represented by its reduction in midstream energy (MPLX) and its exit from traditional banking (U.S. Bancorp)—and toward the "intellectual" infrastructure of the future. The massive entry into ICON Public Limited Company is the cornerstone of this thesis. It signals a belief that in an increasingly complex global economy, the companies that manage complexity (clinical trials, IT distribution, niche credit underwriting) will capture a disproportionate share of the profit pool.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

Sources and limitations

This report uses public U.S. Securities and Exchange Commission Form 13F disclosures and structured data maintained by 13F Hub. A 13F filing is a quarter-end snapshot of reportable long positions, is normally published with a delay, and does not disclose every short position, cash balance, bond, derivative, or non-U.S. asset.

Narrative content is prepared from the same-period SEC disclosure and 13F Hub structured data, then checked before publication. This material is for research and education, not personalized investment advice.